176 related articles for article (PubMed ID: 6748228)
1. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
Kato H; Nagaya T; Torigoe T
Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I
Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
5. The use of a tumor antigen TA-4 for the management of squamous cell carcinoma.
Kato H; Tamai K; Nagaya T; Nagai M; Torigoe T
Cancer Detect Prev; 1985; 8(1-2):155-9. PubMed ID: 4064035
[TBL] [Abstract][Full Text] [Related]
6. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
Kato H; Tamai K; Magaya T; Nagai M; Noguchi H; Suehiro Y; Torigoe T
Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
[TBL] [Abstract][Full Text] [Related]
9. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
Ievleva ES; Ermoshina NV; Ageenko AI
Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
[TBL] [Abstract][Full Text] [Related]
10. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistological evaluation of the cancer associate antigen (TA-4) for pathoclinical management of the cervical malignancy].
Kimura A; Shibata K; Hoshina M; Maruo T; Mochizuki M
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2248-54. PubMed ID: 6533207
[No Abstract] [Full Text] [Related]
12. Flow cytometric analysis of tumor antigen TA-4 in cervical squamous cells.
Sasaki K; Nagai M; Kato H; Torigoe T; Nagamine Y; Takahashi M
Gan; 1984 Aug; 75(8):703-6. PubMed ID: 6386588
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay for tumor-antigen of human cervical squamous cell carcinoma.
Kato H; Morioka H; Aramaki S; Torigoe T
Cell Mol Biol Incl Cyto Enzymol; 1979; 25(1):51-6. PubMed ID: 533610
[No Abstract] [Full Text] [Related]
14. Squamous cell carcinoma related antigen in uterine cervical carcinoma.
Cheah PL; Yap SF; Looi LM; Sivanesaratnam V
Malays J Pathol; 1991 Jun; 13(1):37-41. PubMed ID: 1795560
[TBL] [Abstract][Full Text] [Related]
15. [Flow cytofluorometric analysis for screening cervical squamous cell carcinoma using specific antibody to a tumor antigen TA-4].
Nagai M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):612-6. PubMed ID: 6715941
[TBL] [Abstract][Full Text] [Related]
16. [Establishment and characterization of TA-4 producing cell line (OMC-1) originating from a human squamous cell carcinoma of the uterine cervix].
Ueda M; Maeda T; Yamada T; Miyawaki Y; Otsuki Y; Okamoto Y; Okamura S; Sano T; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1071-8. PubMed ID: 3746026
[TBL] [Abstract][Full Text] [Related]
17. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
18. Tumor antigen TA-4: an aid in detecting post-operative recurrences of esophageal carcinoma.
Sugimachi K; Kitamura M; Matsuda H; Okudaira Y
Dis Markers; 1987 Jun; 5(2):67-73. PubMed ID: 3502985
[TBL] [Abstract][Full Text] [Related]
19. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.
Kato H; Tamai K; Morioka H; Nagai M; Nagaya T; Torigoe T
Cancer; 1984 Oct; 54(8):1544-6. PubMed ID: 6478396
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of recombinant squamous cell carcinoma antigen and leupin/SCCA-2: implications for tumor marker detection.
Barnes RC; Coulter J; Worrall DM
Gynecol Oncol; 2000 Jul; 78(1):62-6. PubMed ID: 10873412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
